UCSF scientists uncovered a common genetic driver of aggressive meningiomas, which could help clinicians detect dangerous cancers earlier and lead to new therapies.
UCSF’s School of Medicine placed in the top five nationally in this year’s U.S. News & World Report survey of best graduate and professional schools. UCSF’s biomedical science PhD programs were among the top 10, and the School of Nursing was also highly ranked.
A new study in mice reveals how a gene mutation seen in human short-sleepers may allow them to survive and thrive on just a few hours of sleep.
UCSF Chancellor Sam Hawgood announced March 13 that Edward Chang will be the inaugural William K. Bowes Jr. Biomedical Investigator.
A study of patients with early Parkinson’s disease found that groups with lower levels of vitamin B12 faced on average a more rapid acceleration of both motor and cognitive symptoms.
UCSF scientists have shown that in the human hippocampus neurogenesis declines throughout childhood and is undetectable in adults.
UCSF received more than $593.9 million in federal funding from the National Institutes of Health in 2017 for research across multiple health-science arenas at the University.
New research led by David Solomon, an assistant professor in the Department of Pathology at UCSF, provides much-needed targeted treatment options for patients whose tumors cannot be surgically removed.
Loss of an enzyme that modifies gene activity to promote brain regeneration may be partly responsible for age-related cognitive decline, according to new research in laboratory mice by UCSF.
Many researchers have long assumed that most stem cells in the body can produce new cells indefinitely, but new research at UCSF shows that this is not the case in the brain.